Christopher Lafollette, MD
Family Medicine · Bloomington, INNPI 1528173341
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (37.4%), other and education — rather than concentrated in one kind of arrangement. 5 manufacturers reported payments, led by Abbott at 34.9% of the total. 2025 is the largest year on record at $84, 4.4 times the $19 reported in 2020. That places this record below the midpoint for family medicine clinicians in IN, where the typical reported total is $501.
Across 6 payments — averaging $23.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$50
- E.r. Squibb & Sons, L.L.C.$40
- Amgen$19
- Edwards Lifesciences$18
- Exact Sciences$16
What the payments were for
- Food & beverage$5337%
- Education$4028%
- Other$5035%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 1 | $50 |
| E.r. Squibb & Sons, L.L.C. | 2 | $40 |
| Amgen | 1 | $19 |
| Edwards Lifesciences | 1 | $18 |
| Exact Sciences | 1 | $16 |
How this compares
$143 in reported general payments places this provider in the 25th percentile of 2,709 family medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 143 | $170,438 |
| MounjaroTirzepatide | 139 | $164,380 |
| OzempicSemaglutide | 58 | $92,687 |
| TrulicityDulaglutide | 37 | $62,929 |
| EliquisApixaban | 45 | $56,447 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 25 | $35,355 |
| JanuviaSitagliptin Phosphate | 36 | $33,783 |
| FarxigaDapagliflozin Propanediol | 17 | $26,418 |
| TradjentaLinagliptin | 19 | $18,882 |
| Breo ElliptaFluticasone/Vilanterol | 29 | $14,939 |
| CreonLipase/Protease/Amylase | 18 | $11,445 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 40 | $8,874 |
| Rosuvastatin Calcium | 520 | $7,986 |
| Atorvastatin Calcium | 571 | $6,624 |
| Jentadueto XrLinagliptin/Metformin Hcl | 13 | $6,603 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Bloomington
- James AndryBloomington$715K
- Michael PorvaznikBloomington$18K
- Richard TannerIndianapolis$1.6M
- Richard FeldmanIndianapolis$476K
- Anthony InzerelloEvansville$308K
- Joe BanksIndianapolis$294K
- Steven GatewoodElwood$281K
- Shekar PushpalaCarmel$239K
- Victoria MoyerKokomo$188K
- Thomas KintanarFort Wayne$185K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.